Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Gene variation affects prostate issues and hair loss.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Certain Dibenzo derivatives may help treat prostate cancer.

DHT stops hair regrowth in mice, similar to human hair loss.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

ROS may affect hair loss related to hormones.

A new gene, JMJD1C, may affect testosterone levels in men.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Apigenin and ellagic acid may help manage PCOS symptoms.

Some dibenzo compounds might help treat cancer with fewer side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.